XML 54 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Schedule of share repurchase program

Year Ended

December 31,

(In thousands, except share and per share data)

2024

2023

Number of shares repurchased

195,518

Total share repurchased cost

$

3,508

$

Average total cost per repurchased share

$

17.94

$

Schedule of allocation of total stock-based compensation expense

Year Ended

December 31, 

(In thousands)

2024

    

2023

    

2022

Cost of revenue

$

365

$

420

$

367

Sales and marketing expenses

2,413

2,985

4,060

Research and development expenses

157

133

226

Reimbursement, general and administrative expenses

4,884

4,009

4,947

Total stock-based compensation expense

$

7,819

$

7,547

$

9,600

Schedule of estimated fair values and assumptions for stock options granted

    

2022

Expected term

 

4.5 years

Expected volatility

 

59.2%

Risk-free interest rate

 

4.3%

Expected dividend yield

 

0%

Fair value on the date of grant

 

$ 8.11

Schedule of stock option activity

    

Weighted-

Weighted-

Average

Average

Aggregate

Options

Exercise Price

Remaining

Intrinsic

(In thousands except options and per share data)

Outstanding

Per Share (1)

Contractual Life

Value (2)

Balance at December 31, 2021

915,224

$

39.33

5.0 years

$

2,068

Granted

47,280

$

6.17

Exercised

(90,878)

$

1.68

$

916

Forfeited

(92,981)

$

36.28

Cancelled/Expired

(163,338)

$

37.65

Balance at December 31, 2022

615,307

$

43.25

4.7 years

$

164

Exercised

(4,625)

$

2.97

$

98

Forfeited

(25,045)

$

47.54

Cancelled/Expired

(155,677)

$

50.72

Balance at December 31, 2023

429,960

$

40.74

3.8 years

$

223

Exercised

(2,571)

$

9.40

$

18

Cancelled/Expired

(32,518)

$

43.63

Balance at December 31, 2024

394,871

$

40.70

2.8 years

$

309

Options exercisable at December 31, 2024

386,990

$

41.36

2.8 years

$

238

(1)The exercise price of each option granted during the periods shown was equal to the market price of the underlying stock on the date of grant.
(2)The aggregate intrinsic value of options exercised represents the difference between the exercise price of the option and the closing stock price of our common stock on the date of exercise. The aggregate intrinsic value of options outstanding represents the difference between the exercise price of the option and the closing stock price of our common stock on the last trading day of the period.
Schedule of non-vested stock options

Year Ended

December 31,

Number of:

2024

2023

Non-vested options, beginning of the year

43,503

179,944

Non-vested options, end of the year

7,881

43,503

Vested options, end of the year

386,990

386,457

Year Ended

December 31,

Weighted-average grant date fair value of:

2024

2023

Non-vested options, beginning of the year

$

13.57

$

16.24

Non-vested options, end of the year

4.23

13.57

Vested options, end of the year

16.52

16.51

Forfeited options, during the year

18.36

Time-Based Restricted Stock Units  
Schedule of stock-settled restricted stock unit activity

Weighted-

    

    

Average Grant

    

Aggregate

Units

Date Fair Value

Intrinsic

(In thousands except unit and per unit data)

Outstanding

Per Unit

Value (1)

Balance at December 31, 2021

259,147

$

42.32

$

4,932

Granted

539,525

$

15.03

Vested

(123,528)

$

43.20

Cancelled

(84,602)

$

26.91

Balance at December 31, 2022

590,542

$

19.42

$

6,779

Granted

398,698

$

15.52

Vested

(270,651)

$

20.18

Cancelled

(129,447)

$

19.79

Balance at December 31, 2023

589,142

$

16.35

$

8,425

Granted

541,547

$

13.82

Vested

(281,917)

$

17.38

Cancelled

(120,346)

$

14.78

Balance at December 31, 2024

728,426

$

14.33

$

12,478

(1)The aggregate intrinsic value of time-based restricted stock units outstanding was based on our closing stock price on the last trading day of the period.
Performance-based stock-settled restricted stock units  
Schedule of stock-settled restricted stock unit activity

Weighted-

    

    

Average Grant

    

Aggregate

PSUs

Date Fair Value

Intrinsic

(In thousands except unit and per unit data)

Outstanding

Per Unit

Value (1)

Balance at December 31, 2021

54,317

$

50.22

$

1,034

Granted

131,710

$

18.54

Vested

(4,407)

$

12.31

Cancelled

(26,002)

$

42.53

Balance at December 31, 2022

155,618

$

25.05

$

1,786

Granted

123,575

$

15.28

Vested

(13,842)

$

42.70

Cancelled

(67,119)

$

21.50

Balance at December 31, 2023

198,232

$

18.93

$

2,785

Granted

223,762

$

13.76

Vested

(44,162)

$

27.31

Cancelled

(104,913)

$

14.14

Balance at December 31, 2024

272,919

$

15.19

$

4,675

(1)The aggregate intrinsic value of performance-based restricted stock units outstanding was based on our closing stock price on the last trading day of the period